Welcome to BioSeeker Group!

Analytical Tool - Breast Cancer

Additional Information

Published Date Apr 22, 2013
Format PDF & Desktop App plus Online Access to Updates (One Year)
Publisher BioSeeker Group

Availability: In stock

€3,100.00

Quick Overview

The ultimate tool for serious players who would like to understand the current competitive field in breast cancer drug development.
Request free sample pages from Analytical Tool - Breast Cancer

"Analytical Tool - Breast Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in breast cancer R&D and business development. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are two products already appreciated by many of our customers:


The Package Includes

  • A progress analysis on current and emerging drugs
  • Information on most companies active in breast cancer R&D
  • Information on key industry related breast cancer projects
  • Data from most important clinical trials
  • Information on early developmental stage projects
  • Possibility of performing advanced searches suited to your individual needs

This Tool will Assist You in:

  • Tracking cutting edge companies, therapies and new technologies
  • Rapid identification of partners & competitors
  • Laying down a comprehensive framework for further analysis of the field
  • Producing presentations surrounding the development of breast cancer therapeutics
  • Identifying emerging breast cancer products & key areas of pharmaceutical R&D

*This software application is a searchable database reflects the most recent advances in the field of breast cancer drug development, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes. A significant advantage with BioSeeker’s software applications is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker’s software applications give better overview, specific search capabilities and great dynamic reports.

Request free sample pages from Analytical Tool - Breast Cancer

Other selected research from the 'Analytical Tool' category:


Analytical Tool - Melanoma
This report offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in melanoma R&D. Learn More


Analytical Tool - Prostate Cancer
A unique tool for analyzing the complex competitive pressure within the field of prostate cancer. Learn More

Other selected research from the 'R&D' category:


Nucleic Acid Therapies in Oncology Drug Pipeline Update 2013
BioSeeker Group have identified 221 companies plus partners who are today developing 256 nucleic acid therapy drugs in 567 developmental projects in cancer across 187 different targets. In addition, there are 7 suspended drugs and another 180 drugs where development has been ceased. Learn More


RANKL Signaling Pathway in Oncology Drug Pipeline Update 2013
BioSeeker Group have identified 185 companies plus partners who are today developing 252 RANKL pathway targeting drugs in 934 developmental projects in cancer across 121 different targets. In addition, there is 1 suspended drug and another 114 drugs where development has been ceased. Learn More

Other selected research from the 'Oncology' category:


Peptides in Oncology Drug Pipeline Update 2013
BioSeeker Group have identified 227 companies plus partners who are today developing 203 peptide drugs in 465 developmental projects in cancer across 177 different targets. In addition, there are 5 suspended drugs and another 122 drugs where development has been ceased. Learn More


Cellular Therapy in Oncology Drug Pipeline Update 2013
BioSeeker Group have identified 72 companies plus partners who are today developing 59 cellular therapy drugs in 127 developmental projects in cancer across 25 different targets. In addition, there are 5 suspended drugs and another 62 drugs where development has been ceased. Learn More